Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n)
2,5-Dimethoxy-4-propylphenethylamine (2C-P) is a hallucinogenic designer drug of the phenethylamine class, the so-called 2Cs, named according to the ethyl spacer between the nitrogen and the aromatic ring. The aims of the present work were to identify the phases I and II metabolites of 2C-P. In addi...
Published in: | Analytical and Bioanalytical Chemistry |
---|---|
Main Authors: | , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Springer Verlag
2015
|
Subjects: | |
Online Access: | http://okina.univ-angers.fr/publications/ua11183 https://doi.org/10.1007/s00216-014-8083-2 |
id |
ftunivangokina:oai:okina.univ-angers.fr:11183 |
---|---|
record_format |
openpolar |
spelling |
ftunivangokina:oai:okina.univ-angers.fr:11183 2023-05-15T15:52:42+02:00 Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) C.S.D. Wink M.R. Meyer T. Braun A. Turcant H.H. Maurer 2015 http://okina.univ-angers.fr/publications/ua11183 https://doi.org/10.1007/s00216-014-8083-2 eng eng Springer Verlag Analytical and Bioanalytical Chemistry 2C-P GC-MS LC-HR-MS n Metabolism Phenethylamine derivatives Article scientifique dans une revue à comité de lecture 2015 ftunivangokina https://doi.org/10.1007/s00216-014-8083-2 2017-04-13T17:46:56Z 2,5-Dimethoxy-4-propylphenethylamine (2C-P) is a hallucinogenic designer drug of the phenethylamine class, the so-called 2Cs, named according to the ethyl spacer between the nitrogen and the aromatic ring. The aims of the present work were to identify the phases I and II metabolites of 2C-P. In addition, the detectability of 2C-P and its metabolites in urine as proof of an intake in clinical or forensic cases was tested. According to the identified metabolites, the following pathways were proposed: N-acetylation; deamination followed by reduction to the corresponding alcohol and oxidation to carbonic acid; mono- and bis-hydroxylation at different positions; mono- and bis-O-demethylation, followed by glucuronidation, sulfation, or both; and combination of these steps. Proof of an intake of a common user's dose of 2C-P was possible by both standard urine screening approaches, the GC-MS as well as the LC-MS(n) approach. Article in Journal/Newspaper Carbonic acid Université Angers: Okina (Open Knowledge, INformation, Access) Analytical and Bioanalytical Chemistry 407 3 831 843 |
institution |
Open Polar |
collection |
Université Angers: Okina (Open Knowledge, INformation, Access) |
op_collection_id |
ftunivangokina |
language |
English |
topic |
2C-P GC-MS LC-HR-MS n Metabolism Phenethylamine derivatives |
spellingShingle |
2C-P GC-MS LC-HR-MS n Metabolism Phenethylamine derivatives C.S.D. Wink M.R. Meyer T. Braun A. Turcant H.H. Maurer Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
topic_facet |
2C-P GC-MS LC-HR-MS n Metabolism Phenethylamine derivatives |
description |
2,5-Dimethoxy-4-propylphenethylamine (2C-P) is a hallucinogenic designer drug of the phenethylamine class, the so-called 2Cs, named according to the ethyl spacer between the nitrogen and the aromatic ring. The aims of the present work were to identify the phases I and II metabolites of 2C-P. In addition, the detectability of 2C-P and its metabolites in urine as proof of an intake in clinical or forensic cases was tested. According to the identified metabolites, the following pathways were proposed: N-acetylation; deamination followed by reduction to the corresponding alcohol and oxidation to carbonic acid; mono- and bis-hydroxylation at different positions; mono- and bis-O-demethylation, followed by glucuronidation, sulfation, or both; and combination of these steps. Proof of an intake of a common user's dose of 2C-P was possible by both standard urine screening approaches, the GC-MS as well as the LC-MS(n) approach. |
format |
Article in Journal/Newspaper |
author |
C.S.D. Wink M.R. Meyer T. Braun A. Turcant H.H. Maurer |
author_facet |
C.S.D. Wink M.R. Meyer T. Braun A. Turcant H.H. Maurer |
author_sort |
C.S.D. Wink |
title |
Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
title_short |
Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
title_full |
Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
title_fullStr |
Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
title_full_unstemmed |
Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n) |
title_sort |
biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2c-p) studied in urine by gc-ms, lc-ms(n), and lc-high-resolution-ms(n) |
publisher |
Springer Verlag |
publishDate |
2015 |
url |
http://okina.univ-angers.fr/publications/ua11183 https://doi.org/10.1007/s00216-014-8083-2 |
genre |
Carbonic acid |
genre_facet |
Carbonic acid |
op_source |
Analytical and Bioanalytical Chemistry |
op_doi |
https://doi.org/10.1007/s00216-014-8083-2 |
container_title |
Analytical and Bioanalytical Chemistry |
container_volume |
407 |
container_issue |
3 |
container_start_page |
831 |
op_container_end_page |
843 |
_version_ |
1766387807038734336 |